The Identification of IL-4 as a Regulator of Chimeric Antigen Receptor T Cell Exhaustion
Carli M. Stewart(WinnMed), Saad S. Kenderian(Mayo Clinic in Arizona), İsmail Can(Mayo Clinic in Arizona), Nathalie Scholler(Gilead Sciences (United States)), Wazim Mohammed Ismail(Mayo Clinic), Mike Mattie, Justin A. Budka(Gilead Sciences (United Kingdom)), Olivia Sirpilla, Ekene J. Ogbodo(Mayo Clinic), Simone Filosto(Gilead Sciences (United States)), Alexandre Gaspar‐Maia(Mayo Clinic), Truc Huynh(Mayo Clinic), Jenny Kim(Gilead Sciences (Australia)), James H. Girsch(Mayo Clinic), Brooke Kimball(Mayo Clinic), Claudia Manriquez Roman(Mayo Clinic), Reona Sakemura(Mayo Clinic), Kun Yun(Xijing Hospital), Michelle J. Cox(WinnMed), Long Mai(Mayo Clinic), Elizabeth L. Siegler(Mayo Clinic)
Cited by 1
Related Papers
MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition
|Cancer Cell|2017|619
Clinical characteristics and outcomes of Richter transformation: experience of 204 patients from a single center
|Haematologica|2019|134
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells
|Nucleic Acids Research|2014|123
Clinical utilization of Chimeric Antigen Receptor T-cells (CAR-T) in B-cell acute lymphoblastic leukemia (ALL)–an expert opinion from the European Society for Blood and Marrow Transplantation (EBMT) and the American Society for Blood and Marrow Transplantation (ASBMT)
|Bone Marrow Transplantation|2019|119